Fiscal Cliff Stock Reports: Amarantus Biosciences, Cellceutix Corporation, World Moto, Facebook, Ford Motor Company
NEW YORK, December 27, 2012 /PRNewswire/ --
The Stock Freak has a team of well diverse market professionals that has combined
experience of over 30 years that today are providing members with a quick research report
on 4 companies.
Amarantus Biosciences (OTC:AMBS) - Amarantus Biosciences, Inc., a development-stage
biotechnology company, focuses on the discovery and development of therapeutic proteins
and biologics for the treatment of Parkinson's disease, traumatic brain injury (TBI), and
other human diseases in the United States. AMBS was up 70% during the trading day
yesterday with the company announcing that it has acquired Neurodegenerative Diagnostic
Intellectual Property Portfolio from Power3 Medical Products.
Cellceutix Corporation (OTC:CTIX) Cellceutix Corporation has once again made to one of
the most active traded stocks on the OTC markets. Yesterday the stock opened at $ 2.29
traded more than 2 million shares with above average volume to close at $2.42 representing
a gain of 9%.
World Moto (OTC:FARE) World Moto Still continues to be one of the most active stocks
in the OTC markets. The company released news yesterday stating that it has introduced a
comprehensive road map to advance the global motorcycle taxi industry. Chris Ziomkowski,
CTO for World Moto, stated, "The potential that the current motorcycle taxi fleets
represent is enormous, and the similarities of the industry to the early days of the
internet cannot be ignored."
Facebook Inc (NASDAQ:FB) - Facebook said on Thursday of last week that it has begun
testing a system that would allow people to send messages to people outside of their
immediate social contact for a payment of one dollar. On Dec 17th 2012 Chief operating
Officer Sheryl Sandberg sold 226,341 shares at $26.76 price per share for a total sum of $
6,057,560.00
Ford Motor Company (NYSE:F) - Ford Motor Company was one of the most active stocks
traded yesterday on the NYSE. The Stock traded over 140 million shares closing up 3%. On
Dec 20th Director Edsel Ford sold 40,000.00 shares
Disclosure: TheStockFreak.com is not a registered investment advisor and nothing
contained in any materials should be construed as a recommendation to buy or sell
securities. Investors should always conduct their own due diligence with any potential
investment. The Stock Freak is a wholly owned entity of a financial public relations firm.
Please read our report and visit our website, for complete risks and disclosures.